Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 May;49(5):623-8.
doi: 10.1007/s00120-010-2257-0.

[Urinary tract infections and Urolithiasis]

[Article in German]
Affiliations
Review

[Urinary tract infections and Urolithiasis]

[Article in German]
A Meissner et al. Urologe A. 2010 May.

Abstract

The classic "infection stone" struvite is formed as a result of metabolic activity of urease-positive bacteria from alkaline urine with pH-values above 7.5. Due to improved infection diagnostics and antibiotic therapy, the occurrence of infection-related urinary stones in the western industrialized world decreases, despite the generally increasing prevalence rates of urolithiasis in these societies. Struvite is often associated with other mineral phases. These accessory mineral phases could indicate other, non-infection-related causes of urinary stone formation. Thus, mineral analysis is always recommended. Struvite stones as well as struvite encrustations on urinary tract implants are characterized by rapid growth. The rapid growth-related embedding of urease-positive bacteria in the crystalline material makes the urinary stone a persistent source of recurrent urinary tract infections. According to the German Society of Urology guidelines on urolithiasis, a patient with the diagnosis "infection stone" should be assigned to the "high-risk" patient group. Complete stone and debris removal, as well as a special metaphylaxis strategy are required to initiate successful stone therapy.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Urol Res. 2006 Apr;34(2):146-50 - PubMed
    1. J Urol. 1962 Oct;88:545-62 - PubMed
    1. Int J Antimicrob Agents. 2002 Jun;19(6):488-98 - PubMed
    1. Nephron. 1999;81 Suppl 1:50-9 - PubMed
    1. Curr Opin Urol. 2009 Mar;19(2):205-10 - PubMed

MeSH terms

LinkOut - more resources